Results 41 to 50 of about 16,409 (241)
International Journal of COPD, 2021 Jae-Hwa Choi,1,* Keun-Bae Jeong,1,* You Hyun Park,2 Iseul Yu,1 Seok Jeong Lee,1 Myoung Kyu Lee,1 Sang-Ha Kim,1 Won-Yeon Lee,1 Suk Joong Yong,1 Ji-Ho Lee1 1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea;
Choi JH +9 more
doaj
Efficacy of fluticasone propionate ointment 0.005% in childhood lichen planus
Indian Journal of Paediatric Dermatology, 2020 Background: Treatment of childhood lichen planus (LP) is challenging owing to high rate of relapses. Moreover, majority of treatment options for LP have been extrapolated from studies done in adults.
Abhinav Kumar +3 more
doaj +1 more source
Formulation pre-screening of inhalation powders using computational atom-atom systematic search method [PDF]
, 2014 This is an open access article published under a Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.The synthonic modeling approach provides ...
Collins, Elizabeth +10 more
core +4 more sources
Corticosteroid Exposure in Chronic Rhinosinusitis and Global Airway Disease: Adrenal and Bone Impact
The Laryngoscope, EarlyView.ABSTRACT Objective To investigate cumulative corticosteroid (CC) burden in patients with chronic rhinosinusitis with nasal polyps (CRSwNP), with or without coexisting asthma (global airway disease, GAD), referred for biologic treatment, and to assess the prevalence of CC‐related comorbidities, including secondary adrenal insufficiency, osteopenia and ...
Christiane Haase +7 more
wiley +1 more source
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events [PDF]
, 2009 Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe ...
Altman +74 more
core +1 more source
Respirology, EarlyView.ABSTRACT Chronic obstructive pulmonary disease (COPD) remains the third leading cause of death worldwide, and conventional bronchodilator‐based therapies have limited efficacy in preventing exacerbations and disease progression. The 2024–2026 period represents a historic inflection point: three mechanistically distinct agents received Food and Drug ...
Naoya Fujino, Hisatoshi Sugiura
wiley +1 more source
The Scientific World Journal, 2014 The effect of duration of administration of fluticasone propionate and salmeterol on tracheal responsiveness to ovalbumin and total and differential white blood cell in sensitized guinea pig was examined.
Zahra Gholamnezhad +4 more
doaj +1 more source
Real-world research and its importance in respiratory medicine [PDF]
, 2015 Peer reviewedPublisher ...
Brusselle, Guy +4 more
core +6 more sources
Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts
Allergy, EarlyView.We surveyed experts of the ARIA group on the costs of medications for allergic rhinitis in the respective countries. Overall, oral antihistamines are the cheapest medications while fixed combinations of antihistamines + corticosteroids are the most expensive.
Maria Clara Urbano +75 more
wiley +1 more source
PLoS ONE, 2019 Recent evidence indicates that AZD8999 (LAS190792), a novel muscarinic acetylcholine receptor antagonist and β2-adrenoceptor agonist (MABA) in development for chronic respiratory diseases, induces potent and sustained relaxant effects in human bronchi by
Javier Milara +7 more
doaj +1 more source